KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Leases (2019 - 2025)

Boston Scientific (BSX) has disclosed Leases for 7 consecutive years, with $465.0 million as the latest value for Q4 2025.

  • Quarterly Leases rose 3.56% to $465.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $465.0 million through Dec 2025, up 3.56% year-over-year, with the annual reading at $465.0 million for FY2025, 3.56% up from the prior year.
  • Leases hit $465.0 million in Q4 2025 for Boston Scientific, down from $495.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $495.0 million in Q3 2025 to a low of $386.0 million in Q4 2022.
  • Historically, Leases has averaged $430.8 million across 5 years, with a median of $428.0 million in 2024.
  • Biggest five-year swings in Leases: soared 33.44% in 2021 and later decreased 11.26% in 2022.
  • Year by year, Leases stood at $435.0 million in 2021, then dropped by 11.26% to $386.0 million in 2022, then rose by 13.73% to $439.0 million in 2023, then grew by 2.28% to $449.0 million in 2024, then rose by 3.56% to $465.0 million in 2025.
  • Business Quant data shows Leases for BSX at $465.0 million in Q4 2025, $495.0 million in Q3 2025, and $492.0 million in Q2 2025.